• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Teleflex Incorporated

    6/28/24 1:15:48 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care
    Get the next $TFX alert in real time by email
    11-K 1 a202311-k6302024.htm 11-K Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549



    FORM 11-K

    (Mark One)

    x    ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the fiscal year ended December 31, 2023

    OR

    o    TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the transition period from _________________________________ to ______________________________

    Commission File Number: 001-05353
    ____________________

    A.Full title of the plan and the address of the plan, if different from that of the issuer named below:

    Teleflex 401(k) Savings Plan


    B.Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

    Teleflex Incorporated
    550 East Swedesford Road, Suite 400
    Wayne, Pennsylvania 19087





    TELEFLEX 401(k) SAVINGS PLAN

    AUDITED FINANCIAL STATEMENTS AND SCHEDULE

    Years Ended December 31, 2023 and 2022



    TABLE OF CONTENTS
    Page No.
    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM2
    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (Predecessor Auditor)
    3
    AUDITED FINANCIAL STATEMENTS
    Statements of Net Assets Available for Benefits4
    Statements of Changes in Net Assets Available for Benefits5
    Notes to Financial Statements6
    SUPPLEMENTAL SCHEDULE
    Schedule H, Line 4i - Schedule of Assets (Held at End of Year)12
    SIGNATURE13
    INDEX TO EXHIBITS
    14


    -1-


    Report of Independent Registered Public Accounting Firm

    Plan Administrator and Participants
    Teleflex 401(k) Savings Plan
    Wayne, Pennsylvania

    Opinion on the Financial Statements

    We have audited the accompanying statements of net assets available for benefits of the Teleflex 401(k) Savings Plan (the “Plan”) as of December 31, 2023, the related statement of changes in net assets available for benefits for the year then ended, and the related notes (collectively, the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2023, and the changes in net assets available for benefits for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

    Basis for Opinion

    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

    We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.

    Our audit included performing procedures to assess the risk of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by the Plan’s management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

    Supplemental Information

    The supplemental information in the accompanying schedule of assets (held at end of year) as of December 31, 2023, has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is presented for the purpose of additional analysis and is not a required part of the financial statements but included supplemental information required by the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. The supplemental information is the responsibility of the Plan’s management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated, in all material respects, in relation to the financial statements as a whole.

    /s/ BDO USA, P.C.

    We have served as the Plan’s auditor since 2024.

    Philadelphia, Pennsylvania
    June 28, 2024
    -2-


    Report of Independent Registered Public Accounting Firm (Predecessor Auditor)

    To the Plan Administrator and Plan Participants
    Teleflex 401(k) Savings Plan
    Wayne, Pennsylvania

    Opinion on the Financial Statements

    We have audited the accompanying statement of net assets available for benefits of the Teleflex 401(k) Savings Plan (the Plan) as of December 31, 2022, and the related statement of changes in net assets available for benefits for the year then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2022, and the changes in net assets available for benefits for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

    Restatement of the 2022 Financial Statements

    As discussed in Note A to the financial statements, the accompanying 2022 financial statements have been restated to correct a classification.

    Basis for Opinion

    These financial statements are the responsibility of the Plan's management. Our responsibility is to express an opinion on the Plan's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

    We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

    Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

    We served as the Plan’s auditor from at least 2004 to 2024. In 2024, we became the predecessor auditor.

    /s/ Maillie, LLP
    Limerick, Pennsylvania
    June 26, 2023 (June 28, 2024 as to the effects of the restatement discussed in Note A)
    -3-

    TELEFLEX 401(k) SAVINGS PLAN
    STATEMENTS OF NET ASSETS
    AVAILABLE FOR BENEFITS
    December 31, 2023 and 2022

    20232022
    Assets
    Cash and cash equivalents$— $6,077 
    Investments, at fair value
    Registered investment companies249,143,441 429,219,706 
    Common collective trusts
    306,593,414 33,360,576 
    Common stock fund52,439,108 59,305,287 
    Total investments, at fair value
    608,175,963 521,885,569 
    Receivables
    Participant loans receivable7,203,389 6,259,332 
    Net assets
    Available for benefits$615,379,352 $528,150,978 
































    See accompanying notes
    -4-

    TELEFLEX 401(k) SAVINGS PLAN
    STATEMENTS OF CHANGES IN NET ASSETS
    AVAILABLE FOR BENEFITS
    For the years ended December 31, 2023 and 2022

    20232022
    Additions to net assets
    Contributions
    Employer $17,874,886 $16,731,644 
    Employee34,012,643 31,526,638 
    Rollover 10,770,335 4,217,926 
    Other contributions2,182 17,420 
    Total contributions62,660,046 52,493,628 
    Investment income (loss)
    Interest and dividends8,104,670 17,471,333 
    Net appreciation (depreciation) in fair value of investments
    74,784,700 (132,620,072)
    Total investment income (loss)
    82,889,370 (115,148,739)
    Interest Income on participant loans
    426,732 366,193 
    Total additions (deductions)
    145,976,148 (62,288,918)
    Deductions from net assets
    Benefits paid to participants58,222,174 63,200,561 
    Administrative fees510,585 418,990 
    Other deductions15,015 2,182 
    Total deductions58,747,774 63,621,733 
    Net increase (decrease)
    87,228,374 (125,910,651)
    Net assets available for benefits
    Beginning of year528,150,978 654,061,629 
    End of year$615,379,352 $528,150,978 















    See accompanying notes

    -5-

    TELEFLEX 401(k) SAVINGS PLAN
    NOTES TO FINANCIAL STATEMENTS
    December 31, 2023 and 2022

    Note A — General description of the plan and summary of significant accounting policies

    General Description of the Plan

    A general description of the Teleflex 401(k) Savings Plan (the “Plan”) follows. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.

    General - The Plan is a defined contribution plan, which was implemented effective July 1, 1985. Certain employees of Teleflex Incorporated (the “Company”) or one of its related entities that is a participating employer in the Plan who have attained age 21 are eligible to participate in the Plan. Full-time and part-time employees are eligible to enter the Plan at their date of hire. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (ERISA).

    The Plan includes an employee stock ownership plan (ESOP) feature, as defined in Section 4975(e)(7) of the Internal Revenue Code of 1986, as amended (Code). The ESOP feature permits a participant to elect to have any dividend paid on the shares of Company common stock allocated to his or her account either paid in cash or deposited into his or her account in the ESOP portion of the Plan and reinvested in the Company common stock fund.

    Safe Harbor Plan/Automatic Contributions - The Plan is intended to satisfy the requirements to be a “qualified automatic contribution arrangement” (QACA) with the meaning of Code Sections 401(k)(13) and 401(m)(12), as well as an “eligible automatic contribution arrangement” (EACA) within the meaning of Code Section 414(w). The EACA permits a penalty-free distribution of “accidental” automatic deferrals made to the Plan within 90 days of the effective date of a participant’s first automatic contribution. The QACA is a safe harbor plan design that allows the Plan to automatically satisfy annual nondiscrimination tests (the actual deferral percentage (ACP) and the actual contribution percentage (ACP) tests.

    Under the safe harbor design, once a participant becomes eligible to participate in the Plan, the participant is automatically enrolled at a 3% deferral rate unless opting out of the automatic deferral feature. Thereafter, the automatic deferral percentage increases by 1% each year up to a maximum automatic deferral of 10%. As part of the QACA, the Company makes “Safe Harbor Matching Contributions” in an amount equal to 100% of a participant’s “elective deferral contributions”, described below, up to 5% of the participant’s compensation.

    Contributions - Participants were able to contribute up to the lesser of $22,500 and $20,500 or 50% of their annual compensation during 2023 and 2022, respectively. These contributions are referred to as “elective deferral contributions” and are withheld from participant’s pay on a pre-tax basis for federal income tax and most state income tax purposes. However, participants may designate all or part of their elective deferral contributions as “Roth elective deferral contributions.” Roth elective deferral contributions are made on an after-tax basis for federal income tax purposes.

    In addition, participants who reach age 50 or older and contribute the maximum permitted under the Plan may make an additional pre-tax contribution (a “catch-up contribution”) of up to $7,500 and $6,500 during 2023 and 2022, respectively. As with regular elective deferral contributions, participants may elect to designate all or part of their catch-up contributions as after-tax “Roth catch-up contributions.” Participants may also contribute amounts representing distributions from other qualified benefit plans (via a rollover contribution into the Plan). As stated above, the Company makes employer Safe Harbor Matching Contributions equal to 100% of elective deferral contributions (including Roth elective deferral contributions and catch-up contributions) up to 5% of compensation. For purposes of calculating contributions, compensation is limited to a maximum of $330,000 and $305,000 during 2023 and 2022, respectively.

    Participant Accounts - Each participant’s account is credited with the participant’s contribution and the employer matching contribution, as well as an allocation of Plan earnings. Participants may access their accounts via a website and toll-free telephone number. Fund transfers and investment election changes may be elected daily or once in a 30-day timeframe depending on the fund type. A participant may stop, start, or change their 401(k) salary deferral rate at will.

    -6-

    TELEFLEX 401(k) SAVINGS PLAN
    NOTES TO FINANCIAL STATEMENTS
    December 31, 2023 and 2022
    Plan Loans - Active employees may elect to take up to two loans from the Plan at any given time. As required by law, a loan amount is limited to the lesser of $50,000 or 50% of the participant’s vested account and must be repaid within five years unless the loan is for the purchase of a primary residence. The loans are secured by the balance in the participant's account and bear a fixed interest rate over the term of the loan. The interest rate is established on the date the loan is granted at prime rate plus 2%. Loan repayments are processed via payroll deduction on an after-tax basis. The entire unpaid balance on any outstanding loan and all interest due thereon will be processed as a taxable distribution and will reduce the participant’s distributable account balance if any of the following occur: (i) a participant fails to make an installment payment due under the loan by the last day of the calendar quarter following the calendar quarter in which the required installment payment was due; (ii) a participant on a leave of absence has an unpaid amount for a period of a year; or (iii) a participant incurs a severance from employment.

    Vesting - Participants are always 100% vested in their own 401(k) elective deferral contributions. With the exception of certain discretionary employer contributions (if any) that become 100% vested after participants have completed three years of employment, the Company’s Safe Harbor Matching Contributions become 100% vested after participants have completed two years of employment.

    Payment of Benefits - The Plan provides that a participant may elect to withdraw 100% of his or her vested account balance at the termination of employment. A participant who is an employee and has attained age 59½ may elect to withdraw any portion of his non-forfeitable account in accordance with the procedures established by the Plan Administrator. Withdrawals shall be made on a pro-rata basis if a Participant elects to make a withdrawal from more than one sub-account in his account. In addition, a participant may elect a hardship withdrawal, as defined by the Plan, of his or her elective deferral contributions, Roth elective deferral contributions, catch-up contributions and Roth catch-up contributions. A participant may elect to withdraw his or her rollover account at any time.

    Forfeitures - Forfeitures of terminated participants’ nonvested accounts are used to pay Plan expenses and reduce the amount of future contributions required to be made to the Plan by the Company and the other participating employers in the Plan. The amount of unallocated forfeitures at December 31, 2023 and 2022 were $220,382 and $134,516, respectively. For the year ended December 31, 2023 and 2022, forfeitures used to offset employer contributions were $600,026 and $403,468, respectively.

    Plan Termination - Although it has not expressed any intent to do so, the Company has the right to discontinue its contributions at any time and to terminate the Plan at any time, subject to the provisions set forth in ERISA. In the event of Plan termination, distribution of participant accounts shall be in accordance with ERISA and its applicable regulations and Article XIII of the Plan document.

    Plan Amendments - On November 7, 2022, the Company approved an amendment to the Plan to reflect special rules permitted for the Coronavirus Aid, Relief, and Economic Security (the "CARES Act") to increase the required minimum distribution age from age 70 1/2 to 72 for participants born after June 30, 1949 and to comply with certain Codes in the Setting Every Community Up for Retirement Enhancement Act of 2019 (the "SECURE Act") regarding certain longer-term part-time workers.
    The amendment also allows all employees from Standard Bariatrics, Inc. ("Standard Bariatrics"), which was acquired on September 27, 2022, to participate in the Teleflex 401(k) Savings Plan beginning on January 1, 2023. All Standard Bariatrics employees who met the Company's eligibility criteria were eligible to participate in the Plan and were provided an option to rollover their Standard Bariatrics 401(k) Retirement and Savings Plan assets into the Plan.
    Investments - Participants direct the investment of their contributions into various investment options offered by the Plan. The Plan currently offers several mutual funds, common collective trusts, as well as the Company common stock fund as investment options for participants.
    Effective March 14, 2023, the Plan made a qualified change in investment options available and transferred all balances and contributions from the Vanguard Target Retirement dated funds to the corresponding Vanguard Target Retirement dated trust funds. For example, investments in the Vanguard Target Retirement 2050 fund were transferred to the Vanguard Target Retirement Trust 2050 II. Plan participants were given advance notice of the changes and were allowed to transfer any existing balances in the options being replaced to other remaining options available in the Plan prior to the effective date. The newly adopted Vanguard Target Retirement dated trust funds are valued at net asset value ("NAV").
    -7-

    TELEFLEX 401(k) SAVINGS PLAN
    NOTES TO FINANCIAL STATEMENTS
    December 31, 2023 and 2022
    Significant Accounting Policies

    The significant accounting policies of the Plan employed in the preparation of the accompanying financial statements follow:

    Valuation of investments - The Plan’s investments are stated at fair value pursuant to the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) No. 820, Fair Value Measurements and Disclosures. Fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note E for further information on fair value measurements.

    Participant Loans Receivable - All transactions are measured at their unpaid principal balance plus any accrued but unpaid interest. Any individual credit risk related to participant loans is mitigated by the fact that these loans are secured by the participant’s vested balance. If a participant were to default, the participant’s account balance would be offset by the unpaid balance of the loan, and the participant would be subject to tax on the unpaid loan balance. As such, the participant is the only party affected in the event of a default.

    Revenue Recognition and Method of Accounting - All transactions are recorded on an accrual basis. Purchases and sales of investments are recorded on a trade-date basis. Interest income is accrued when earned. Dividend income is recorded on the ex-dividend date. Capital gain distributions are included in dividend income. Net appreciation (depreciation) includes the gains and losses on investments bought and sold as well as held during the year. Expenses are recorded as incurred.

    Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect certain reported amounts of assets, liabilities and changes therein and disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

    Correction of Investment Classification - The Plan’s investment holdings in the Vanguard Retirement Savings Trust III, was previously classified as a fully benefit responsive investment contract reported at contract value on the December 31, 2022 statement of net assets available for benefits. In 2023, Plan management determined that this investment is a common collective trust that should be reported at fair value using NAV as the practical expedient. As a result, the prior year presentation of this investment balance reported at contract value has been revised to conform with the current year presentation of reporting this investment at fair value in the statement of net assets available for benefits. In addition, the Vanguard Retirement Savings Trust III investment holdings was added to ASC 820 fair value leveling table in Note E as an investment reported at fair value using NAV as the practical expedient, which represents a reconciling item to the ASC 820 fair value leveling table. This revision did not impact the Plan’s previously reported net assets available for benefits amount as of December 31, 2022.

    Note B — Administration of the plan

    The Plan is administered by a committee of at least three members appointed by the Company’s Board of Directors. The committee is the Plan Administrator and fiduciary for ERISA purposes. Charles Schwab Bank (Schwab) is the trustee and third-party administrator of the Plan. Schwab charges a per participant fee for the administrative services that it provides to the Plan. Actively employed participants pay a small portion of the participant fee on a quarterly basis. The Company and any other Company affiliate that participates in the Plan (a "Participating Employer") pay the remaining portion of the fee for participants who are actively employed by the Company or a Participating Employer. Participants who are not actively employed by the Company or a Participating Employer pay the per participant administrative fee from their Plan accounts. Investment management fees charged by each mutual fund are netted against returns. Investment management fees charged by the common collective trust funds are charged to participants with balances in the respective trust.

    Note C — Tax status of the plan

    The Plan obtained its latest determination letter on August 4, 2015, in which the Internal Revenue Service indicated that the Plan, as then designed, was in compliance with the applicable requirements of the Internal Revenue Code (“Code”) (i.e., satisfied the applicable requirements of Code Section 401 et. seq. to be a tax-qualified
    -8-

    TELEFLEX 401(k) SAVINGS PLAN
    NOTES TO FINANCIAL STATEMENTS
    December 31, 2023 and 2022
    plan and satisfied the applicable requirement of Code Section 501 et. seq. for the Plan’s trust to be a tax-exempt trust). Although the Plan has been amended since receiving the determination letter, the Plan administrator and the Plan’s legal counsel believe that the Plan as currently designed, continues to satisfy the applicable requirements of Code Sections 401 and 501 et. seq. to be a tax-qualified plan and tax-exempt trust. In addition, to the knowledge of the Plan administrator and the Plan’s legal counsel, the Plan and its trust are currently being operated in compliance with the applicable requirements of Code Sections 401 and 501 et. seq. and, therefore, the Plan and its related trust are tax-qualified and tax-exempt, respectively.

    Accounting principles generally accepted in the United States of America require the Plan’s management to evaluate tax positions taken by the Plan and recognize a tax liability or asset if the Plan has taken an uncertain position that more likely than not would not be sustained upon examination by the Internal Revenue Service. The Plan Administrator has analyzed the tax positions by the Plan and has concluded that as of December 31, 2023 and 2022, there are no uncertain positions taken or expected to be taken that would require recognition of a liability or asset or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.

    Note D — Related party transactions and party in interest transactions

    The Plan participants invest in shares of the Company’s stock through the Teleflex Incorporated common stock fund. The common stock fund held 209,500 and 235,876 shares of the Teleflex Incorporated common stock representing 8% and 11% of Plan assets as of December 31, 2023 and 2022, respectively. These transactions, in addition to participant loan receivables, qualify as party-in-interest transactions and are exempt from the prohibited transaction rules.

    Certain administrative functions of the Plan are performed by officers or employees of the Company. No such officer or employee received compensation from the Plan.

    Note E — Fair value measurements

    FASB ASC 820 establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under FASB ASC 820 are described as follows:

    Level 1 - inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Plan has the ability to access.

    Level 2 - inputs to the fair value measurement that include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

    Level 3 - inputs to the fair value measurement that are unobservable inputs for the asset or liability.

    The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.





    -9-

    TELEFLEX 401(k) SAVINGS PLAN
    NOTES TO FINANCIAL STATEMENTS
    December 31, 2023 and 2022
    A summary by level within the fair value hierarchy (as defined above) of the Plan’s investments measured at fair value on a recurring basis is as follows:
    Level 1Level 2December 31, 2023
    Registered investment companies$249,143,441 $— $249,143,441 
    Company common stock fund— 52,439,108 52,439,108 
    Total investments in fair value hierarchy
    249,143,441 52,439,108 301,582,549 
    Common collective trusts measured at net asset value (1)
    — — 306,593,414 
    Total investments, at fair value
    $249,143,441 $52,439,108 $608,175,963 
    Level 1Level 2December 31, 2022
    Registered investment companies$429,219,706 $— $429,219,706 
    Company common stock fund— 59,305,287 59,305,287 
    Total investments in fair value hierarchy
    429,219,706 59,305,287 488,524,993 
    Common collective trusts measured at net asset value (1)
    — — 33,360,576 
    Total investments, at fair value
    $429,219,706 $59,305,287 $521,885,569 
    (1)    The common collective trusts are measured at the net asset value of units held at December 31, 2023 and December 31, 2022. In accordance with ASC 820, certain investments that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in the above totals are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statements of net assets available for benefits.
    The following is a description of the valuation methodologies used for assets measured in fair value hierarchy:

    •Registered investment companies are valued at quoted market prices, which represent the net asset value of shares held by the Plan at year end. The funds are deemed to be actively traded.
    •The Company common stock fund is valued at the combined market value of the underlying stock based upon the closing price of the stock on its primary exchange times the number of shares held and the short-term cash component at year end.

    Redemptions for common collective trusts are allowed daily without any restrictions or notice periods, and there are no unfunded commitments.

    Note F — Risks and uncertainties

    Investment securities, in general, are exposed to various risks, such as interest rate, credit, and overall market volatility risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and such changes could materially affect participants’ account balances and the amounts reported in the statement of net assets available for benefits.

    Note G — Subsequent event
    Effective January 1, 2024, the Plan allowed all employees from Palette Life Sciences AB (“Palette”), which was acquired on October 10, 2023, to participate in the Teleflex 401(k) Savings Plan. All Palette employees who met the Company's eligibility criteria were eligible to participate in the Plan and were provided an option to rollover their Palette 401(k) Retirement and Savings Plan assets into the Plan.
    The Plan's Management has evaluated subsequent events through June 28, 2024, the date which the financial statements were issued.
    -10-














    Supplemental Schedule

    -11-

    TELEFLEX 401(k) SAVINGS PLAN
    SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
    Year Ended December 31, 2023
    Plan EIN# 23-1147939, Plan 010

    (b)(c)(e)
    (a)Identity of Issuer, Borrower, Lessor, or Similar PartyDescription of Investment, Including Maturity Date, Rate of Interest, Collateral, Par or Maturity ValueCurrent Value
    American Funds New Perspective Fund; Class R-6Registered Investment Company$3,761,594 
    American Funds New World Fund; Class R6Registered Investment Company2,285,500 
    Columbia Dividend Income: Institutional SharesRegistered Investment Company15,582,738 
    JPMorgan Small Cap Equity Fund; Class R6Registered Investment Company5,275,458 
    Metropolitan West Total Return Bond Fund; P ClassRegistered Investment Company4,000,099 
    Touchstone Midcap R6Registered Investment Company13,310,658 
    Vanguard Explorer Fund: Admiral SharesRegistered Investment Company10,341,713 
    Vanguard Extended Market Index Fund: Institutional SharesRegistered Investment Company8,157,276 
    Vanguard Federal Money Market FundRegistered Investment Company12,428,549 
    Vanguard Inflation-Protected Securities Fund: Admiral SharesRegistered Investment Company2,868,372 
    Vanguard Institutional Index FundRegistered Investment Company49,068,009 
    Vanguard International Growth: Admiral SharesRegistered Investment Company14,083,428 
    Vanguard Real Estate Index: Admiral SharesRegistered Investment Company2,347,467 
    Vanguard Small-Cap Index Fund: Admiral SharesRegistered Investment Company6,577,136 
    Vanguard Total Bond Market Index Fund Institutional SharesRegistered Investment Company12,766,956 
    Vanguard Total International Stock Index Fund Institutional SharesRegistered Investment Company14,800,861 
    Vanguard Total World Stock Index Fund: Admiral SharesRegistered Investment Company6,157,881 
    Vanguard US Growth Admiral SharesRegistered Investment Company36,320,245 
    Vanguard Wellington Fund Admiral SharesRegistered Investment Company29,009,501 
    *Teleflex Stock FundUnitized Stock Fund52,439,108 
    Vanguard Retirement Savings Trust III
    Common Collective Trust Fund
    28,423,941 
    Vanguard Target Retirement 2020 II
    Common Collective Trust Fund
    6,053,506 
    Vanguard Target Retirement 2025 II
    Common Collective Trust Fund
    27,240,379 
    Vanguard Target Retirement 2030 II
    Common Collective Trust Fund
    33,748,768 
    Vanguard Target Retirement 2035 II
    Common Collective Trust Fund
    52,253,553 
    Vanguard Target Retirement 2040 II
    Common Collective Trust Fund
    41,871,895 
    Vanguard Target Retirement 2045 II
    Common Collective Trust Fund
    42,783,094 
    Vanguard Target Retirement 2050 II
    Common Collective Trust Fund
    30,979,886 
    Vanguard Target Retirement 2055 II
    Common Collective Trust Fund
    24,722,857 
    Vanguard Target Retirement 2060 II
    Common Collective Trust Fund
    11,510,091 
    Vanguard Target Retirement 2065 II
    Common Collective Trust Fund
    2,131,993 
    Vanguard Target Retirement 2070 II
    Common Collective Trust Fund
    21,077 
    Vanguard Retirement Income Trust II
    Common Collective Trust Fund
    4,852,374 
    *Participant Loans
    Participant Loans at rates between 5.25% to 11% with various maturities through December 2053
    7,203,389 
    $615,379,352 
    *Party-in-interest.
    Cost information not required as all investments are participant-directed.
    -12-


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
    Teleflex 401(k) Savings Plan
    By:/s/ Cameron P. Hicks
    Cameron P. Hicks
    Corporate Vice President & Chief Human Resource Officer
    Dated: June 28, 2024

    -13-


    INDEX TO EXHIBITS
     
    Exhibit No.Description
    23.1-
    Consent of BDO USA, P.C, Independent Registered Public Accounting Firm (Successor Auditor)
    23.2-
    Consent of Maillie LLP, Independent Registered Public Accounting Firm (Predecessor Auditor)

    -14-
    Get the next $TFX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TFX

    DatePrice TargetRatingAnalyst
    1/27/2026$138.00Hold → Buy
    Needham
    3/4/2025$235.00 → $140.00Neutral → Underperform
    BofA Securities
    2/28/2025$220.00 → $155.00Outperform → Sector Perform
    RBC Capital Mkts
    2/28/2025Outperform → Mkt Perform
    Raymond James
    2/28/2025$255.00 → $140.00Overweight → Neutral
    Piper Sandler
    2/27/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    7/1/2024$205.00 → $245.00Neutral → Overweight
    Piper Sandler
    12/4/2023$261.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $TFX
    SEC Filings

    View All

    Teleflex Incorporated filed SEC Form 8-K: Leadership Update

    8-K - TELEFLEX INC (0000096943) (Filer)

    1/23/26 5:00:20 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - TELEFLEX INC (0000096943) (Filer)

    1/8/26 6:55:45 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Incorporated filed SEC Form 8-K: Regulation FD Disclosure

    8-K - TELEFLEX INC (0000096943) (Filer)

    12/9/25 5:08:17 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Teleflex Announces Leadership Transition

    Stuart Randle Appointed Interim President and CEO Board Initiates Search for Permanent CEO Dr. Stephen Klasko Appointed Chairman of the Board Company Provides Update on Preliminary Full Year 2025 Revenue Results WAYNE, Pa., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) today announced that Stuart Randle, a member of the Company's Board of Directors, has been appointed Interim President and Chief Executive Officer, effective immediately. Mr. Randle succeeds Liam Kelly, who departs as Chairman, President and CEO of the Company. Dr. Stephen Klasko, the Company's Lead Director, has been named Chairman of the Board. The Board has engaged Spencer Stuart, a leading execu

    1/8/26 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction

    Leading Medical Device Designer & Manufacturer to Operate as Independent Company Following Closing of Transaction Montagu and Kohlberg, two leading middle-market private equity firms, today announced that they have entered into a definitive agreement to acquire Teleflex Medical OEM (the "Company") from Teleflex Incorporated (NYSE:TFX) for $1.5 billion in a carve-out transaction. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251208550931/en/ For over 40 years, Teleflex Medical OEM has developed and supplied custom-engineered interventional catheter components and sub-assemblies, as well as surgical fibers and sutures, used acros

    12/9/25 9:20:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

    WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into definitive agreements to sell the company's Acute Care, Interventional Urology and OEM businesses to two buyers, Intersurgical® Ltd with respect to Acute Care and Interventional Urology, and Montagu and Kohlberg with respect to OEM, for a combined total of $2.03 billion in cash, subject to certain closing adjustments. "Over the past year, we have executed a clear strategy to optimize our portfolio and best position Teleflex for the future, with a focus on driving growth across our core critical care and high acuity hospital

    12/9/25 9:04:01 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Teleflex upgraded by Needham with a new price target

    Needham upgraded Teleflex from Hold to Buy and set a new price target of $138.00

    1/27/26 8:35:45 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex downgraded by BofA Securities with a new price target

    BofA Securities downgraded Teleflex from Neutral to Underperform and set a new price target of $140.00 from $235.00 previously

    3/4/25 7:44:32 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Teleflex from Outperform to Sector Perform and set a new price target of $155.00 from $220.00 previously

    2/28/25 7:34:55 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim President and CEO Randle Stuart A was granted 12,325 shares, increasing direct ownership by 163% to 19,872 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    1/15/26 7:18:24 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Director Randle Stuart A bought $115,860 worth of shares (1,000 units at $115.86), increasing direct ownership by 15% to 7,547 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    8/7/25 6:02:01 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Director Krakauer Andrew A bought $115,250 worth of shares (1,000 units at $115.25), increasing direct ownership by 16% to 7,192 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    8/7/25 4:15:44 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Randle Stuart A bought $115,860 worth of shares (1,000 units at $115.86), increasing direct ownership by 15% to 7,547 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    8/7/25 6:02:01 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Director Krakauer Andrew A bought $115,250 worth of shares (1,000 units at $115.25), increasing direct ownership by 16% to 7,192 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    8/7/25 4:15:44 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Chairman, President & CEO Kelly Liam bought $172,605 worth of shares (1,500 units at $115.07), increasing direct ownership by 3% to 45,267 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    8/7/25 4:14:44 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Leadership Updates

    Live Leadership Updates

    View All

    Teleflex Announces Leadership Transition

    Stuart Randle Appointed Interim President and CEO Board Initiates Search for Permanent CEO Dr. Stephen Klasko Appointed Chairman of the Board Company Provides Update on Preliminary Full Year 2025 Revenue Results WAYNE, Pa., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) today announced that Stuart Randle, a member of the Company's Board of Directors, has been appointed Interim President and Chief Executive Officer, effective immediately. Mr. Randle succeeds Liam Kelly, who departs as Chairman, President and CEO of the Company. Dr. Stephen Klasko, the Company's Lead Director, has been named Chairman of the Board. The Board has engaged Spencer Stuart, a leading execu

    1/8/26 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

    3/7/25 6:19:00 PM ET
    $ALK
    $AMBC
    $ATI
    Air Freight/Delivery Services
    Consumer Discretionary
    Property-Casualty Insurers
    Finance

    Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion

    Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, today announced the appointment of Paul Wilson as Chief Commercial Officer (CCO). In this role, Mr. Wilson will lead the company's commercial strategy, overseeing sales, marketing, clinical programming, and business development initiatives. His leadership will help expand awareness, accelerate growth, and strengthen market positioning of Cagent Vascular's proprietary serration balloon technology. Mr. Wilson brings many years of experience in the medical device industry, having held senior commercial leadership positions at Teleflex (NYSE:TFX) and Abbott (NYSE:ABT). With

    3/4/25 11:38:00 AM ET
    $ABT
    $TFX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    $TFX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Teleflex Incorporated

    SC 13G/A - TELEFLEX INC (0000096943) (Subject)

    11/14/24 1:28:29 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Teleflex Incorporated

    SC 13G/A - TELEFLEX INC (0000096943) (Subject)

    11/8/24 10:29:30 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Teleflex Incorporated (Amendment)

    SC 13G/A - TELEFLEX INC (0000096943) (Subject)

    2/14/24 10:04:36 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Financials

    Live finance-specific insights

    View All

    Teleflex Announces Quarterly Dividend

    WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2025, to shareholders of record at the close of business on November 14, 2025. About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiol

    11/6/25 6:45:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook

    WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) (the "Company") today announced financial results for the third quarter ended September 28, 2025. Third quarter financial summary GAAP revenue of $913.0, up 19.4% compared to the prior year periodAdjusted revenue of $892.9 million, up 16.8% compared to the prior year period, and up 15.3% on an adjusted constant currency basis1GAAP diluted EPS from continuing operations of $(9.24), compared to $2.36 in the prior year periodAdjusted diluted EPS from continuing operations of $3.67, compared to $3.49 in the prior year period 2025 guidance summary  Narrowing GAAP revenue growth guidance range to 9.10% to 9.60% Lo

    11/6/25 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

    WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 6, 2025. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company's website, teleflex.com. An audio replay of the call will be available beginning at 11:00 am Eastern Time on November 6, 2025, either on the Teleflex website or by telephone. The call can be accessed by dialing 1 800 770 2030 (U.S. and Canada) or 1 609

    10/16/25 4:30:10 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care